Suzhou Novoprotein Scientific Co., Ltd. (688137)
SSE
99.03
-0.72 (-0.72%)
Closed
Sep 18, 2026
Day's Range
95.55112.00
52 wk Range
33.20112.00
Financial Statements - 688137 - Suzhou Novoprotein Scientific Co., Ltd.
Revenue
146.43M▲ 14.8%
Net Income
-77.78M▼ 42.9%Net Margin -53.1%
EBITDA
-6.71M▼ 139.6%
Free Cash Flow
-92.24M▼ 192.2%
Income Statement
| Period Ending | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | 2020-12-31 |
|---|---|---|---|---|---|---|
| Sales | 146.43M | 127.55M | 153.19M | 264.55M | 341.89M | 179.84M |
| Cost of Goods | 48.14M | 47.98M | 37.27M | 36.18M | 42.07M | 19.32M |
| Gross Profit | 98.29M | 79.56M | 115.91M | 228.36M | 299.82M | 160.51M |
 Operating Expense | - | - | - | - | - | - |
| Operating Income | -66.68M | -55.39M | -5.89M | 112.92M | 193.85M | 103.81M |
| Non-Operating Interest | - | - | - | - | - | - |
| Other Income Expense | - | - | - | - | - | - |
| Pre Tax Income | -70.37M | -54.21M | 6.22M | 106.18M | 176.23M | 94.14M |
| Income Tax | 7.40M | 198.01K | -6.62M | 15.46M | 27.22M | 11.10M |
| Net Income | -77.78M | -54.41M | 12.84M | 90.72M | 149M | 83.04M |
| EPS Basic | -1.11 | -0.78 | 0.18 | 1.59 | 3.73 | - |
| EPS Diluted | -1.11 | -0.78 | 0.18 | 1.59 | 3.73 | - |
| Basic Shares Outstanding | 70.07M | 69.76M | 71.35M | 57.05M | 39.94M | - |
| Diluted Shares Outstanding | 70.07M | 69.76M | 71.35M | 57.05M | 39.94M | - |
| Ebit | -67.82M | -50.63M | 9.80M | 110.23M | 178.02M | 95.15M |
| Ebitda | -6.71M | 16.93M | 66.38M | 146.54M | 203.81M | 103.39M |
| Net Income Continuous Operations | -77.78M | -54.41M | 12.84M | 90.72M | 149M | 83.04M |
| Minority Interests | - | - | - | - | - | - |
| Preferred Stock Dividends | 0 | 0 | 0 | 0 | 0 | 0 |
The information on this page is provided for general informational purposes only and is not investment advice.
Market data provided by Twelve Data. Charting by TradingView.
Last updated:
